Shalby Ltd.
NSE: SHALBY · Hospital
Snapshot
Unlock Shalby Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Shalby Limited is a multi-specialty hospital chain based in India, specialising in orthopaedics and a wide range of surgical and medical services. The company operates a network of 11 hospitals and 50 outpatient clinics, while also providing homecare services and clinical research.
Business Model
The company generates revenue through inpatient hospital services, outpatient consultations, and diagnostic procedures. It further diversifies income streams by offering homecare health services, medical equipment provision, and educational fellowships for healthcare professionals.
- Hospital count:11
- Aggregate bed capacity:2,012
- Outpatient clinics:50
Growth Outlook
Growth is driven by the expansion of its hospital network and the scaling of outpatient clinic operations. The company is also leveraging its international presence and clinical research capabilities to broaden its healthcare service footprint.
Key Risks
- Regulatory and Compliance Risk. The healthcare sector is subject to stringent government regulations regarding pricing, quality standards, and medical licensing.
- Operational Concentration. A significant portion of the company's revenue is derived from orthopaedic services, creating a dependency on this specific medical vertical.
- Talent Retention. The ability to attract and retain highly skilled surgeons and medical professionals is critical to maintaining service quality and reputation.
- Geopolitical Risk. Operating across multiple international markets exposes the company to varying political, economic, and currency risks.
Price
Start your research today
Unlock AI insights, financials, peers and live data on Shalby Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,141 Cr
TTM · consolidated
NET PROFIT
₹35 Cr
TTM · consolidated
EPS
₹3.23
TTM · consolidated
RETURN ON EQUITY
3.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
8.0%
TTM · consolidated
P/E
51.5x
Q4 FY26 · consolidated
EV/EBITDA
13.6x
Q4 FY26 · consolidated
EBITDA MARGIN
14.9%
TTM · consolidated
NET PROFIT MARGIN
6.4%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.5x
Q4 FY26 · consolidated
Peers · Hospital
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Shalby Ltd.SHALBY | 1,466 | 51.54 | 13.59 | 5.0% | 14.9% | 3.5% | 8.0% | -16.4% |
Artemis Medicare Services Ltd.ARTEMISMED | 3,537 | 41.98 | 20.85 | 15.4% | 20.2% | 12.0% | 14.4% | +9.9% |
Gpt Healthcare Ltd.GPTHEALTH | 980 | 29.86 | 14.13 | 16.1% | 19.1% | 16.7% | 19.2% | -12.4% |
Gujarat KidneyGKSL | 812 | — | — | — | 33.0% | — | — | — |
Lotus Eye Hospital And Institute Ltd.LOTUSEYE | 219 | 3064.25 | 58.01 | 8.4% | 8.5% | 0.1% | 1.2% | +59.7% |
Hannah JosephHANNAH | 138 | — | — | — | 27.0% | — | — | — |
As of Q4 FY26
Financials
Shalby Ltd.
NSE: SHALBY · Hospital
Snapshot
Unlock Shalby Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Shalby Limited is a multi-specialty hospital chain based in India, specialising in orthopaedics and a wide range of surgical and medical services. The company operates a network of 11 hospitals and 50 outpatient clinics, while also providing homecare services and clinical research.
Business Model
The company generates revenue through inpatient hospital services, outpatient consultations, and diagnostic procedures. It further diversifies income streams by offering homecare health services, medical equipment provision, and educational fellowships for healthcare professionals.
- Hospital count:11
- Aggregate bed capacity:2,012
- Outpatient clinics:50
Growth Outlook
Growth is driven by the expansion of its hospital network and the scaling of outpatient clinic operations. The company is also leveraging its international presence and clinical research capabilities to broaden its healthcare service footprint.
Key Risks
- Regulatory and Compliance Risk. The healthcare sector is subject to stringent government regulations regarding pricing, quality standards, and medical licensing.
- Operational Concentration. A significant portion of the company's revenue is derived from orthopaedic services, creating a dependency on this specific medical vertical.
- Talent Retention. The ability to attract and retain highly skilled surgeons and medical professionals is critical to maintaining service quality and reputation.
- Geopolitical Risk. Operating across multiple international markets exposes the company to varying political, economic, and currency risks.
Price
Loading…
Start your research today
Unlock AI insights, financials, peers and live data on Shalby Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,141 Cr
TTM · consolidated
NET PROFIT
₹35 Cr
TTM · consolidated
EPS
₹3.23
TTM · consolidated
RETURN ON EQUITY
3.5%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
8.0%
TTM · consolidated
P/E
51.5x
Q4 FY26 · consolidated
EV/EBITDA
13.6x
Q4 FY26 · consolidated
EBITDA MARGIN
14.9%
TTM · consolidated
NET PROFIT MARGIN
6.4%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.5x
Q4 FY26 · consolidated
Peers · Hospital
As of Q4 FY26